so far it was a warm up.

I am not as enthused re VP sales appointment as the following paragraph;
"Phase 2 involves a more targeted and collaborative clinical
engagement strategy. We will further engage with G
Ps and other medical professionals to drive product
awareness and make the AirSonea available directly t
o the asthma community, via well-respected retail
outlets, predominantly pharmacies. We are regularly
engaging with these clients and are confident this
plan will be successfully executed with key commercial
executives in place to drive our agenda. We are
confident the AirSonea will change the historical tr
eatment methods of trial and error into one of
evidenced based personalised medical care.”

I like the bit about key commercial executives to drive agenda. Also a collaborative clinical engagement strategy.
It seems that they realized after the GP's convention in Darwin that when a medico (asthma specialist, gp or even nurse) is explained the device on a one to one, he/she becomes the beginning and source of all sales decisions.
Makes a lot of sense to me.
I believe , once a critical mass of these professionals strongly endorse/prescribe it , internet sales along with pharmacy sales will take off exponentially. Webinars to doctors , as proposed by u-health, in lieu of one on one contact , will not do the trick imo. They will only be watched by the converted. My thoughts only.

In terms of technicals. I feel that there is a much greater than 50% probability we have seen bottom.